[ALNY] QoQ Quarter Result on 30-Sep-2010 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
04-Nov-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- 34.19%
YoY- -4.58%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 20,614 20,897 21,192 27,668 26,617 24,564 26,626 -15.72%
PBT -13,824 -16,285 -6,503 -9,332 -14,861 -12,305 -8,230 41.43%
Tax -1,593 -1,802 427 298 -229 18 -439 136.69%
NP -13,824 -16,285 -6,930 -9,630 -14,632 -12,323 -7,791 46.71%
Tax Rate - - - - - - - -
Total Cost 34,438 37,182 28,122 37,298 41,249 36,887 34,417 0.04%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin -67.06 -77.93 -32.70 -34.81 -54.97 -50.17 -29.26 74.09%
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
EPS -0.33 -0.38 -0.16 -0.23 -0.35 -0.29 -0.19 44.63%
EPS Diluted -0.33 -0.38 -0.16 -0.23 -0.35 -0.29 -0.19 44.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.